Hideyuki Tozaki - Concepedia

Author

Hideyuki Tozaki

Kyoto Pharmaceutical University

Also Known As

H Tozaki, Hideyuki TOZAKI, Hideyuki Tozaki

Publications

908

Citations

H-Index

Concepts

All Affiliations

Kyoto Pharmaceutical University Ono Pharmaceutical (Japan)

About

Hideyuki Tozaki is an author at Kyoto Pharmaceutical University specializing in pharmacology, medicine, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	391
2	Gastroenterology	4	4	310
3	Biomedical Engineering	3	3	274
4	Biochemistry	2	2	61
5	Diabetes	2	2	41

Hideyuki Tozaki

Publications

876

Citations

H-Index

Page 1

	Year	Citations
Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon Hideyuki Tozaki, Junta Komoike, Chika Tada, Journal of Pharmaceutical Sciences	1997	314
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats Hideyuki Tozaki, Tomokazu Odoriba, Naoki Okada, Journal of Controlled Release InflammationChitosan CapsulesMedicineGastroenterologyBiomedical Engineering	2002	198
Degradation of Insulin and Calcitonin and Their Protection by Various Protease Inhibitors in Rat Caecal Contents: Implications in Peptide Delivery to the Colon Hideyuki Tozaki, Yasuharu Emi, Eri Horisaka, Journal of Pharmacy and Pharmacology	1997	83
Enhanced Absorption of Insulin and (Asu1,7)Eel‐Calcitonin using Novel Azopolymer‐Coated Pellets for Colon‐Specific Drug Delivery Hideyuki Tozaki, Junko Nishioka, Junta Komoike, Journal of Pharmaceutical Sciences MedicinePharmaceutical TechnologyDrug Delivery SystemsEnhanced AbsorptionColon‐specific Drug Delivery	2001	58
Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: Therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats Hideyuki Tozaki, Takuya Fujita, Tomokazu Odoriba, Life Sciences InflammationAnti-inflammatoryMedicineChitosan CapsulesImmunology	1999	56
Validation of a Pharmacokinetic Model of Colon-specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5-Aminosalicylic Acid on 2,4,6-Trinitrobenzenesulphonic Acid-induced Colitis in Rats Hideyuki Tozaki, Takuya Fujita, Tomokazu Odoriba, Journal of Pharmacy and Pharmacology	1999	40
Use of Protease Inhibitors to Improve Calcitonin Absorption from the Small and Large Intestine in Rats Hideyuki Tozaki, Tomokazu Odoriba, Tomoya Iseki, Journal of Pharmacy and Pharmacology Protease InhibitorsImprove Calcitonin AbsorptionGastrointestinal Peptide HormoneBiochemistryMedicine	1998	38
Colon-specific Delivery of Budesonide with Azopolymer-coated Pellets: Therapeutic Effects of Budesonide with a Novel Dosage Form against 2,4,6-Trinitrobenzenesulphonic Acid-induced Colitis in Rats Hideyuki Tozaki, Takuya Fujita, Junta Komoike, Journal of Pharmacy and Pharmacology	1999	35
Metabolism of peptide drugs by the microorganisms in rat cecal contents. Hideyuki Tozaki, Eri Horisaka, Akira Yamamoto, Biological and Pharmaceutical Bulletin BiochemistryColon-specific Drug DeliveryMedicineBioanalysisPhysiology	1995	23
Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon. Hideyuki Tozaki, Akira Yamamoto, Shozo Muranishi Drug Delivery System Insulin AbsorptionGastrointestinal PharmacologyChitosan CapsulesDiabetesGlycobiology	1997	18

Page 1